Trending

CSL

After Celgene deal, BMS shoots up pharma market cap rankings

After Celgene deal, BMS shoots up pharma market cap rankings

Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies

X

After Celgene deal, BMS shoots up pharma market cap rankings

https://pharmaphorum.com/news/after-celgene-deal-bms-shoots-up-pharma-market-cap-rankings/

Australia’s CSL on the rise as profits increase 30%

Australia’s CSL on the rise as profits increase 30%

US operations pull in revenues

X

Australia’s CSL on the rise as profits increase 30%

https://pharmaphorum.com/news/australias-csl-rise-profits-increase-30/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com